Nu Skin Enterprises, Inc. ( NUS ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants B.G. Hunt Ryan Napierski - President, CEO & Director James Thomas - Executive VP & CFO Conference Call Participants David Storms - Stonegate Capital Partners, Inc., Research Division Presentation Operator Good day, and thank you for standing by.
NUS' Q3 results may reflect revenue pressure, but cost savings and efficiency gains are likely to have helped sustain earnings.
Nu Skin Enterprises, Inc. (NYSE:NUS ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants B.G. Hunt - Corporate Participant James D.
| Household Products Industry | Consumer Staples Sector | Ryan S. Napierski CEO | XFRA Exchange | US67018T1051 ISIN |
| US Country | 3,100 Employees | 28 Nov 2025 Last Dividend | - Last Split | 21 Nov 1996 IPO Date |
Nu Skin Enterprises, Inc. is a multinational corporation that has carved its niche in the development and distribution of premium beauty and wellness products on a global scale. Since its inception in 1984, the company has been at the forefront of offering innovative skin care devices, cosmetics, personal care products, and wellness supplements. Headquartered in Provo, Utah, Nu Skin leverages a unique business model, distributing its wide array of products through a combination of retail channels, its website, digital platforms, and a network of independent direct sellers and marketers. Additionally, it places a strong emphasis on research and product development, particularly in the realms of skin care and nutritional supplements, underlining its commitment to quality and efficacy.
Under its umbrella, Nu Skin Enterprises, Inc. markets a diverse range of products across various brands, each designed to cater to specific beauty and wellness needs:
In addition to offering these products under the Nu Skin, Pharmanex, and ageLOC brands, the company remains dedicated to pushing the boundaries of what's possible in skin care and nutrition through ongoing research and development efforts.